1-4 of 4
Natalie Nguyen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

Carlos I. Amaya-Chanaga, MD, Michael Y. Choi, MD, Natalie Nguyen, B.Sc, Elizabeth DeVore, B.Sc, Colin MacCarthy, B.Sc, Jacqueline Hilger-Rolfe, PhD, M.S., Thomas J. Kipps, MD, PhD, Januario E. Castro, MD
Journal: Blood
Blood (2016) 128 (22): 2048.
https://doi.org/10.1182/blood.V128.22.2048.2048
Published: 2016
Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Colin MacCarthy, B.Sc, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 2051.
https://doi.org/10.1182/blood.V128.22.2051.2051
Published: 2016
Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Amine Ale-Ali, PharmD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 4160.
https://doi.org/10.1182/blood.V126.23.4160.4160
Published: 2015
Journal Articles

A Liposomal Formulation of KRN7000 (RGI-2001) Potently Reduces GvHD Lethality through the Expansion of CD4 + Foxp3 + Regulatory T Cells in Murine Models

Omar Duramad, PhD, Amy Laysang, Jun Li, Natalie Nguyen, Yasuyuki Ishii, PhD, Reiko Namikawa, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3500.
https://doi.org/10.1182/blood.V112.11.3500.3500
Published: 2008